Cowen Inc’s Agios Pharmaceuticals AGIO Stock Holding History

Cowen Inc’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-30,000	Closed	-$114K	–	449
2019 Q1	$114K	Buy	+30,000	New	+$1.75M	0.01%	227

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cowen Inc's AGIO Position: Q3 2015 in Review

Cowen Inc sold out of Agios Pharmaceuticals (AGIO) in Q3 2015, closing a stake of 4,950 shares — an estimated $550K sold.

Cowen Inc first reported a position in AGIO in Q4 2014 and held it in 3 quarters. The position peaked at $1.6M in Q4 2014. 151 funds tracked by Wall St. Rank hold AGIO as of Q3 2015.

Cowen Inc reported no remaining Agios Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Cowen Inc sold 4,950 Agios Pharmaceuticals shares in Q3 2015, an estimated $550K.
Cowen Inc first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 3 quarters.
Cowen Inc's Agios Pharmaceuticals position peaked at $1.6M in Q4 2014.
151 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2015.

Based on Cowen Inc's 13F filing for Q3 2015, filed 13 Nov 2015.